We are live on ! Find out more
ORIAU

Orion Biotech Opportunities Corp. Units
ORIAU

Delisted

ORIAU was delisted on the 25th of April, 2023.

Back to rankings

6 hedge funds and large institutions have $15.7M invested in Orion Biotech Opportunities Corp. Units in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

25% less capital invested

Capital invested by funds: $21M → $15.7M (-$5.22M)

45% less funds holding

Funds holding: 11 → 6 (-5)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
-5
Holders Change %
-45.45%
% of All Funds
0.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
–
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$3.68M
2
WC
Wealthspring Capital
New York
-$972K
3
Millennium Management
Millennium Management
New York
-$323K
4
SMA
Sage Mountain Advisors
Georgia
-$149K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$101K

ORIAU Hedge Fund Activity: Q4 2022 in Review

6 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Units (ORIAU) for Q4 2022, worth a combined $15.7M — down 25% from $21M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ORIAU and 1 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Jane Street, exiting entirely with an estimated $3.68M sold.

  • 6 institutional investors held Orion Biotech Opportunities Corp. Units (ORIAU) as of Q4 2022, down from 11 in Q3 2022.
  • Funds reported $15.7M of Orion Biotech Opportunities Corp. Units stock for Q4 2022, down 25% quarter-over-quarter.
  • 1 fund opened new Orion Biotech Opportunities Corp. Units positions in Q4 2022 and 6 closed out, a net change of -5 holders.
  • The largest Orion Biotech Opportunities Corp. Units seller in Q4 2022 was Jane Street, an estimated $3.68M sold.

Based on aggregated 13F filings for Q4 2022.